APOE -: 491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease

被引:33
|
作者
Casadei, VM
Ferri, C
Veglia, F
Gavazzi, A
Salani, G
Cattaneo, M
Sorbi, S
Annoni, G
Licastro, F
Mariani, C
Franceschi, M
Grimaldi, LME
机构
[1] Ist Sci San Raffaele, Clin Santa Maria Castellanza, Neuroimmunol Unit, Dept Neurosci, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Clin Santa Maria Castellanza, Neuroimmunol Unit, Biostat Unit, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, Clin Santa Maria Castellanza, Dept Neurol, I-20132 Milan, Italy
[4] CNR, Ist Tecnol Biomed Avanzate, I-20131 Milan, Italy
[5] Univ Florence, Dept Neurol & Psychiat Sci, I-50121 Florence, Italy
[6] Univ Milan, Dept Geriatr, I-20122 Milan, Italy
[7] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy
[8] IRCCS Santa Maria Nascente, Neurorehabil Unit, Milan, Italy
[9] IRCCS Oasi Maria Santissima, Troina, Italy
关键词
APOE; AD; polymorphisms;
D O I
10.1212/WNL.53.8.1888
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1888 / 1889
页数:2
相关论文
共 50 条
  • [1] Assocation of the APOE promoter polymorphisms with late-onset Alzheimer's disease
    Minster, RL
    Desai, PP
    Öztürk, A
    Chen, Q
    Ganguli, M
    Nebes, RD
    Reynolds, CF
    DeKosky, ST
    Kamboh, MI
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S512 - S513
  • [2] A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease
    Crawford, FC
    Freeman, MJ
    Schinka, JA
    Abdullah, LI
    Gold, M
    Hartman, R
    Krivian, K
    Morris, MD
    Richards, D
    Duara, R
    Anand, R
    Mullan, MJ
    [J]. NEUROLOGY, 2000, 55 (06) : 763 - 768
  • [3] Monoamine oxidase A polymorphism in Brazilian patients - Risk factor for late-onset Alzheimer's disease?
    Nishimura, AL
    Guindalini, C
    Oliveira, JRM
    Nitrini, R
    Bahia, VS
    de Brito-Marques, PR
    Otto, PA
    Zatz, M
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2005, 27 (02) : 213 - 217
  • [4] Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population
    Koivisto, AM
    Helisalmi, S
    Pihlajamäki, J
    Moilanen, L
    Kuusisto, J
    Laakso, M
    Hiltunen, M
    Keijo, V
    Hänninen, T
    Helkala, EL
    Kervinen, K
    Kesäniemi, YA
    Soininen, H
    [J]. JOURNAL OF NEUROGENETICS, 2005, 19 (3-4) : 155 - 161
  • [5] Monoamine oxidase a polymorphism in brazilian patientsRisk factor for late-onset Alzheimer’s disease?
    Agnes L. Nishimura
    Camila Guindalini
    João R. M. Oliveira
    Ricardo Nitrini
    Valéria S. Bahia
    Paulo R. de Brito-Marques
    Paulo A. Otto
    Mayana Zatz
    [J]. Journal of Molecular Neuroscience, 2005, 27 : 213 - 217
  • [6] Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease
    Wang, JC
    Kwon, JM
    Shah, P
    Morris, JC
    Goate, A
    [J]. NEUROLOGY, 2000, 55 (11) : 1644 - 1649
  • [7] The Fas promoter polymorphism at position-670 is not associated with late-onset sporadic Alzheimer's disease
    Rosenmann, H
    Meiner, Z
    Kahana, E
    Aladjem, Z
    Friedman, G
    Ben-Yehuda, A
    Grenader, T
    Wertman, E
    Abramsky, O
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (03) : 143 - 146
  • [8] The-463G/A myeloperoxidase promoter polymorphism is associated with reduced risk for late-onset sporadic Alzheimer's disease.
    Manna, I
    Andreoli, V
    La Russa, A
    La Porta, G
    Nicoletti, G
    Serra, P
    Cittadella, R
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 266 - 266
  • [9] The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism
    Town, T
    Paris, D
    Fallin, D
    Duara, R
    Barker, W
    Gold, M
    Crawford, F
    Mullan, M
    [J]. NEUROSCIENCE LETTERS, 1998, 252 (02) : 95 - 98
  • [10] APOE polymorphisms and late-onset Alzheimer disease -: The importance of ethnicity
    Kukull, WA
    Martin, GM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (10): : 788 - 789